Met-Lys-Bradykinin
CAS: 550-19-6
Ref. 3D-FM108622
5mg | 212,00 € | ||
10mg | 347,00 € | ||
25mg | 615,00 € | ||
50mg | 999,00 € | ||
100mg | 1.632,00 € |
Produktinformation
- H-Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH H-MKRPPGFSPFR-OH
- Bradykinin, met-lys-
- Bradykinin, methionyl-lysine-
- Met-lys-bradykinin
- Bradykinin, N2-(N2-L-methionyl-L-lysyl)-
- L-methionyl-L-lysyl-N~5~-(diaminomethylidene)-L-ornithyl-L-prolyl-L-prolylglycyl-L-phenylalanyl-L-seryl-L-prolyl-L-phenylalanyl-N~5~-(diaminomethylidene)-L-ornithine
- H-Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH
Met-Lys-Bradykinin is a synthetic peptide with the amino acid sequence Met-Lys-Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg. It has been shown to have cytosolic Ca2+ release activity, protease activity, and vasodilator activities. The peptide also has binding affinity for human immunoglobulin G (IgG) and is able to form complexes with soybean trypsin.
Met-Lys-Bradykinin has been shown to induce hemocyte aggregation in ascidian larvae, which is the first step of the inflammatory process. The peptide also induces acetylcholine release from human erythrocytes and increases contractile responses in isolated rat phrenic nerve diaphragm preparations. This indicates that it may be an effective therapeutic agent for treatment of bronchial asthma or chronic obstructive pulmonary disease (COPD).
Chemische Eigenschaften
Technische Anfrage zu: 3D-FM108622 Met-Lys-Bradykinin
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.